Lcnb Corp Pfizer Inc Transaction History

Lcnb Corp

$280 Million
Q2 2025

A detailed history of Lcnb Corp transactions in Pfizer Inc stock. As of the latest transaction made, Lcnb Corp holds 13,038 shares of PFE stock, worth $356,850. This represents 0.11% of its overall portfolio holdings.

Number of Shares

13,038

Previous 13,343 2.29%

Holding current value

$356,850

Previous $338,000 6.51%

% of portfolio

0.11%

Previous 0.13%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$21.59 - $24.84 $6,584 - $7,576	-305 Reduced 2.29%	13,038 $316,000
Q1 2025 May 12, 2025	SELL	$25.01 - $27.13 $664,190 - $720,491	-26,557 Reduced 66.56%	13,343 $338,000
Q4 2024 Feb 11, 2025	BUY	$24.8 - $30.19 $6,200 - $7,547	250 Added 0.63%	39,900 $1.06 Million
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $6,980 - $7,910	252 Added 0.64%	39,650 $1.15 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $69,667 - $81,636	2,758 Added 7.53%	39,398 $1.1 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $22,265 - $25,567	860 Added 2.4%	36,640 $1.02 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $25,006 - $32,480	957 Added 2.75%	35,780 $1.03 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $96 - $112	-3 Reduced 0.01%	34,823 $1.16 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $51,218 - $59,258	-1,418 Reduced 3.91%	34,826 $1.28 Million
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $30,921 - $40,254	785 Added 2.21%	36,244 $1.48 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $37,157 - $48,505	890 Added 2.57%	35,459 $1.82 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $45,510 - $55,556	-1,040 Reduced 2.92%	34,569 $1.51 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $18,612 - $22,068	400 Added 1.14%	35,609 $1.87 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $25,025 - $31,009	-547 Reduced 1.53%	35,209 $1.82 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $52,889 - $78,400	1,280 Added 3.71%	35,756 $2.11 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $71,827 - $92,268	1,830 Added 5.61%	34,476 $1.48 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $27,830 - $31,527	775 Added 2.43%	32,646 $1.28 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $56,296 - $63,491	-1,681 Reduced 5.01%	31,871 $1.16 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $21,272 - $24,957	-670 Reduced 1.96%	33,552 $1.23 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $6,867 - $8,331	228 Added 0.67%	34,222 $1.12 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $54,357 - $77,664	2,011 Added 6.29%	33,994 $1.11 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $14,418 - $16,363	438 Added 1.39%	31,983 $1.25 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $75,929 - $98,457	2,337 Added 8.0%	31,545 $1.13 Million
Q2 2019 Aug 01, 2019	BUY	$36.98 - $41.52 $1,664 - $1,868	45 Added 0.15%	29,208 $1.27 Million
Q1 2019 May 02, 2019	BUY	$37.5 - $41.2 $26,025 - $28,592	694 Added 2.44%	29,163 $1.24 Million
Q4 2018 Feb 19, 2019	SELL	$38.47 - $43.86 $17,811 - $20,307	-463 Reduced 1.6%	28,469 $1.24 Million
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $26,955 - $32,695	782 Added 2.78%	28,932 $1.28 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $81,460 - $86,845	2,470 Added 9.62%	28,150 $1.02 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $40,844 - $47,385	-1,280 Reduced 4.75%	25,680 $911,000
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $6,652 - $7,058	-200 Reduced 0.74%	26,960 $977,000
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $10,478 - $11,542	-338 Reduced 1.23%	27,160 $969,000
Q2 2017 Aug 14, 2017	BUY	N/A	27,498	27,498 $924,000

Others Institutions Holding PFE

# of Institutions

3,296

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.

Account